Higher cumulative exposure to systemic antibiotic therapy may be associated with higher risk for the development of inflammatory bowel disease, according to research published in Lancet Gastroenterology & Hepatology.

Jonas F. Ludvigsson, MD, of the department of medical epidemiology and biostatistics at Karolinska Institutet in Sweden, and colleagues wrote that learning how environmental and other factors impact the development of IBD is critical.

“Globally, rates of IBD are rising, particularly in areas undergoing rapid economic development,” they wrote. “Since these

Full Article: https://www.healio.com/news/gastroenterology/20200825/number-of-antibiotic-dispensations-potentially-linked-with-ibd-development